Trends in Epidemiology, Clinical and Histopathological Characteristics of Breast Cancer in Iran: Results of a 17 Year Study |
Afsharfard, Aboulfazl
(Department of Surgery, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences)
Mozaffar, Mohammad (Department of Surgery, Shohadaye Tajrish Hospital, Shahid Beheshti University of Medical Sciences) Orang, Elahe (Islamic Azad University, Tehran Medical Branch) Tahmasbpour, Eisa (Young Research Club, Islamic Azad University) |
1 | Agarwal G, Pradeep PV, Aggarwal V, et al (2007). Spectrum of breast cancer in Asian women. World J Surg, 31, 1031-40. DOI ScienceOn |
2 | Benz CC (2008). Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol, 66, 65-74. DOI ScienceOn |
3 | Botteri E, Bagnardi V, Goldhirsch A, et al (2010). Axillary lymph node involvement in women with breast cancer: does it depend on age? Clin Breast Cancer, 10, 318-21. DOI ScienceOn |
4 | Colleoni M, Rotmensz N, Robertson C, et al (2002). Very young women (<35 years) with operable breast cancer: features of disease at presentation. Ann Oncol, 13, 273-9. |
5 | Fisher CJ, Egan MK, Smith P, et al (1997). Histopathology of breast cancer in relation to age. Br J Cancer, 75, 593-6. DOI |
6 | Fleming ID, Cooper JS, Henson DE, et al (1997). American Joint Committee on Cancer: AJCC Cancer Staging Manual, 5th edition. Philadelphia, PA: Lippincott- Raven. |
7 | Foxcroft LM, Evans EB, Porter AJ (2004). The diagnosis of breast cancer in women younger than 40. Breast, 13, 2-306. |
8 | Gennari R, Curigliano G, Rotmensz N, et al (2004). Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer, 101, 1302-10. DOI ScienceOn |
9 | Harirchi I, Ebrahimi M, Zamani N, et al (2000). Breast cancer in Iran: a review of 903 case records. Public Health, 114, 143-5. |
10 | Harirchi I, Karbakhsh M, Kashefi A, et al (2004). Breast cancer in Iran: results of a multi-center study. Asian Pac J Cancer Prev, 5, 24-7. |
11 | Harirchi I, Karbakhsh M, Montazeri A, et al (2010). Decreasing trend of tumor size and downstaging in breast cancer in Iran: results of a 15-year study. Eur J Cancer Prev, 19, 126-30. DOI ScienceOn |
12 | Harirchi I, Kolahdoozan S, Karbakhsh M, et al (2011). Twenty years of breast cancer in Iran: downstaging without a formal screening program. Ann Oncol, 22, 93-7. DOI ScienceOn |
13 | Karihtala P, Winqvist R, Bloigu R, et al (2010). Long-term observational follow-up study of breast cancer diagnosed in women 40 years old. Breast, 19, 456-61. DOI ScienceOn |
14 | Medical Advisory Secretariat (2007). Screening Mammography for women aged 40 to 49 Years at average risk for breast cancer: an evidence-based analysis. Ontario Health Technology Assessment Series ,7, 1-29. |
15 | Mohammad K, Sadat Hashemi SM, Farahani FK (2004). Age at natural menopause in Iran. Maturitas, 49, 321-6. DOI ScienceOn |
16 | Molino A, Giovannini M, Auriemma A, et al (2006). Pathological, biological and clinical characteristics, and surgical management, of elderly women with breast cancer. Crit Rev Oncol Hematol, 59, 226-33. DOI ScienceOn |
17 | Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91. DOI ScienceOn |
18 | Mousavi SM, Harirchi I, Ebrahimi M, et al (2008). Screening for breast cancer in Iran: a challenge for health policy makers. Breast J, 14, 605-6. DOI ScienceOn |
19 | Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63. |
20 | Orang E, Tahmasbpour E, Afsharfard A (2013). Predictive role of tumor size in breast cancer with axillary lymph node involvement - can size of primary tumor be used to omit an unnecessary axillary lymph node dissection? Asian Pac J Cancer Prev, 14, 717-22. DOI ScienceOn |
21 | Parkin DM, Bray F, Ferley J, et al (2001). Estimating the world cancer burden: Globocan 2000. Int J Cancer, 94, 153-6. DOI ScienceOn |
22 | Parkin DM, Fernandez LM (2006). Use of statistics to assess the global burden of breast cancer. Breast J, 12, 70-80. DOI ScienceOn |
23 | Porter PL (2009). Global trends in breast cancer incidence and mortality. Salud Publica Mex, 51, 141-6. DOI |
24 | Sharma K, Costas A, Shulman LN, et al (2012). A systematic review of barriers to breast cancer care in developing countries resulting in delayed patient presentation. J Oncol, 121873. |
25 | Shibuya K, Mathers CD, Boschi-Pinto C, et al (2002). Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer, 2, 37. DOI |
26 | Siegel R, Naishadham D, Jemal A (2013). Cancer statistics. CA Cancer J Clin, 63, 11-30. DOI ScienceOn |
27 | Smigal C, Jemal A, Ward E, et al (2006). Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin, 56, 168-83. DOI ScienceOn |
28 | Winchester DP, Osteen RT, Menck HR (1996). The National Cancer Data Base report on breast carcinoma characteristics and outcome in relation to age. Cancer, 78, 1838-43. DOI |
29 | Yancik R, Wesley MN, Ries LA, et al (2001). Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA, 285, 885-92. DOI ScienceOn |